DK0894500T3 - Streptococcus equi-vaccine - Google Patents

Streptococcus equi-vaccine

Info

Publication number
DK0894500T3
DK0894500T3 DK98202512T DK98202512T DK0894500T3 DK 0894500 T3 DK0894500 T3 DK 0894500T3 DK 98202512 T DK98202512 T DK 98202512T DK 98202512 T DK98202512 T DK 98202512T DK 0894500 T3 DK0894500 T3 DK 0894500T3
Authority
DK
Denmark
Prior art keywords
streptococcus equi
equi vaccine
vaccine
vaccines
manufacture
Prior art date
Application number
DK98202512T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32669079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0894500(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0894500T3 publication Critical patent/DK0894500T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98202512T 1997-07-29 1998-07-27 Streptococcus equi-vaccine DK0894500T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202365 1997-07-29
EP98202512A EP0894500B1 (en) 1997-07-29 1998-07-27 Streptococcus equi vaccine

Publications (1)

Publication Number Publication Date
DK0894500T3 true DK0894500T3 (da) 2004-11-15

Family

ID=32669079

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98202512T DK0894500T3 (da) 1997-07-29 1998-07-27 Streptococcus equi-vaccine

Country Status (10)

Country Link
US (1) US6120775A (da)
EP (1) EP0894500B1 (da)
JP (1) JP4563520B2 (da)
AT (1) ATE270112T1 (da)
CA (1) CA2243730C (da)
DE (1) DE69824794T2 (da)
DK (1) DK0894500T3 (da)
ES (1) ES2224331T3 (da)
HU (1) HU223762B1 (da)
PT (1) PT894500E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682745B1 (en) 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
EP1023903B1 (en) * 1999-01-26 2004-01-14 Akzo Nobel N.V. Use of life attenuated bacteria for the manufacture of a submucosal vaccine
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
WO2007126885A2 (en) * 2006-03-28 2007-11-08 The Trustees Of The University Of Pennsylvania Live, attenuated pneumococcal vaccine
WO2007115059A2 (en) * 2006-03-29 2007-10-11 Merial Limited Vaccine against streptococci
US20110020403A1 (en) * 2007-12-13 2011-01-27 Bengt Guss immunizing composition
EA029938B1 (ru) * 2015-04-09 2018-05-31 Тоо "Акынтай" Вакцина против мыта лошадей

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
WO1982004396A1 (en) * 1981-06-19 1982-12-23 Russell Roy Robert Baird Protection against dental caries
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US4788059A (en) * 1985-07-15 1988-11-29 Coopers Animal Health, Inc. Equine strangles vaccine and the method of preparing and using the same
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
DE3853683T2 (de) * 1987-10-07 1995-08-31 Univ Washington Verfahren zur erhaltung eines erwünschten rekombinanten gens in einer genetischen zellpopulation.
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.

Also Published As

Publication number Publication date
HU223762B1 (hu) 2005-01-28
JPH11100329A (ja) 1999-04-13
JP4563520B2 (ja) 2010-10-13
PT894500E (pt) 2004-10-29
ATE270112T1 (de) 2004-07-15
CA2243730A1 (en) 1999-01-29
EP0894500A1 (en) 1999-02-03
ES2224331T3 (es) 2005-03-01
HUP9801705A2 (hu) 1999-05-28
CA2243730C (en) 2009-12-22
HUP9801705A3 (en) 2001-11-28
DE69824794D1 (de) 2004-08-05
DE69824794T2 (de) 2004-11-25
EP0894500B1 (en) 2004-06-30
HU9801705D0 (en) 1998-09-28
US6120775A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINES TO ENHANCE CROSS-PROTECTIVE IMMUNOGENICITY
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
CY2009014I1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
DE69117532D1 (de) Orale präparate
FI931169A7 (fi) Parannetut rokotekoostumukset
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DK0585681T3 (da) Anvendelse af IL-4-receptoren til behandling, forebyggelse og diagnose af infektionssygdomme
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
HUP0203056A1 (hu) Vakcinakészítmény
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
BRPI9700768B8 (pt) vacina viva para combater infecção por streptococcus em cavalos.
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DZ2283A1 (fr) Composition de vaccin.
ATE377428T1 (de) Rotavirus-impfstoff
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
DK0894500T3 (da) Streptococcus equi-vaccine
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK1109574T3 (da) Vaccine mod seksuelt overförte sygdomme
ATE249740T1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
ES2136064T3 (es) Vacunas de toxoide de pasteurella multocida.
DE69936052D1 (de) N1 modifizierte glycopeptide
FR2661809B3 (fr) Diffuseur personnel de parfum ou de desodorisant.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа